{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T04:26:20Z","timestamp":1749788780520,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CRRPG2H0122, CMRPG2C0342, CMRPG2F0073 and CLRPG2L0051","CRRPG2H0122, CMRPG2C0342, CMRPG2F0073 and CLRPG2L0051"],"award-info":[{"award-number":["CRRPG2H0122, CMRPG2C0342, CMRPG2F0073 and CLRPG2L0051","CRRPG2H0122, CMRPG2C0342, CMRPG2F0073 and CLRPG2L0051"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2314-B-182A-127"],"award-info":[{"award-number":["109-2314-B-182A-127"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Associations between hepatitis C virus (HCV) and chronic kidney disease (CKD) have been reported; however, differences of renal progression between general and CKD population remain to be elucidated in prospective studies. A total of 1179 participants, who have tested for anti-HCV antibody, were enrolled and prospectively followed for 3\u00a0years. The risks associated with HCV infection, in terms of incidence of CKD, annual estimated glomerular filtration rate (eGFR) changes and 50% decline of eGFR at 3-year from baseline, were compared between normal renal function subjects and CKD patients. Overall, 111 of 233 (47.6%) CKD patients and 167 of 946 (17.7%) non-CKD subjects had HCV infection. The crude incidence rates of CKD were 226.9 per 1000 person-years and 14.8 per 1000 person-years in in HCV and non-HCV infected patients, respectively. The adjusted hazard ratio of HCV infection for incident CKD was 7.9 (95% CI 5\u201312.7). The HCV-infected normal renal function subjects were independently associated with increased risks of eGFR decline in the 1-year, 2-year and 3-year, respectively. The risk associations remained significant in 50% decline of eGFR at 3\u00a0years models and in different subgroup analyses. The increases of risks of eGFR decline were also notorious among overall HCV-infected CKD patients. However, the risk associations were less prominent in subgroup analyses (elderly, women and diabetic patients). The findings highlighted the importance of viral diagnosis with not only prognostic but also public health implications for preserving kidney function.<\/jats:p>","DOI":"10.1038\/s41598-021-96782-x","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T10:46:44Z","timestamp":1629888404000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Renal function trajectories in hepatitis C infection: differences between renal healthy and chronic kidney disease individuals"],"prefix":"10.1038","volume":"11","author":[{"given":"Cheng-Kai","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Shuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ju","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng-Jung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng-Chih","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hung","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Lang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-Nan","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"96782_CR1","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2019.17379","volume":"8","author":"RG Nelson","year":"2019","unstructured":"Nelson, R. G. et al. Development of risk prediction equations for incident chronic kidney disease. JAMA 8, 2104\u20132114. https:\/\/doi.org\/10.1001\/jama.2019.17379 (2019).","journal-title":"JAMA"},{"key":"96782_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrneph.2009.173","volume":"5","author":"F Kronenberg","year":"2009","unstructured":"Kronenberg, F. Emerging risk factors and markers of chronic kidney disease progression. Nat. Rev. Nephrol. 5, 677\u2013689. https:\/\/doi.org\/10.1038\/nrneph.2009.173 (2009).","journal-title":"Nat. Rev. Nephrol."},{"key":"96782_CR3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jvh.12413","volume":"22","author":"H Park","year":"2015","unstructured":"Park, H., Adeyemi, A., Henry, L., Stepanova, M. & Younossi, Z. A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection. J. Viral. Hepat. 22, 897\u2013905. https:\/\/doi.org\/10.1111\/jvh.12413 (2015).","journal-title":"J. Viral. Hepat."},{"key":"96782_CR4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/ki.2013.455","volume":"85","author":"YC Chen","year":"2014","unstructured":"Chen, Y. C., Lin, H. Y., Li, C. Y., Lee, M. S. & Su, Y. C. A nationwide cohort study suggests that hepatitis C virus infection is associated with increased risk of chronic kidney disease. Kidney Int. 85, 1200\u20131207. https:\/\/doi.org\/10.1038\/ki.2013.455 (2014).","journal-title":"Kidney Int."},{"key":"96782_CR5","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hep.27664","volume":"61","author":"MZ Molnar","year":"2015","unstructured":"Molnar, M. Z. et al. Association of hepatitis C viral infection with incidence and progression of chronic kidney disease in a large cohort of US veterans. Hepatology 61, 1495\u20131502. https:\/\/doi.org\/10.1002\/hep.27664 (2015).","journal-title":"Hepatology"},{"key":"96782_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/hep.29505","volume":"67","author":"H Park","year":"2018","unstructured":"Park, H. et al. Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD. Hepatology 67, 492\u2013504. https:\/\/doi.org\/10.1002\/hep.29505 (2018).","journal-title":"Hepatology"},{"key":"96782_CR7","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/s41598-018-36437-6","volume":"9","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. Association of Hepatitis C and B Virus Infection with CKD and Impact of Hepatitis C Treatment on CKD. Sci. Rep. 9, 1910. https:\/\/doi.org\/10.1038\/s41598-018-36437-6 (2019).","journal-title":"Sci. Rep."},{"key":"96782_CR8","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s10620-016-4199-x","volume":"61","author":"AC Moorman","year":"2016","unstructured":"Moorman, A. C. et al. Prevalence of renal impairment and associated conditions among HCV-infected persons in the chronic hepatitis cohort study (CHeCS). Dig. Dis. Sci. 61, 2087\u20132093. https:\/\/doi.org\/10.1007\/s10620-016-4199-x (2016).","journal-title":"Dig. Dis. Sci."},{"key":"96782_CR9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2215\/cjn.00470107","volume":"2","author":"LS Dalrymple","year":"2007","unstructured":"Dalrymple, L. S. et al. Hepatitis C virus infection and the prevalence of renal insufficiency. Clin. J. Am. Soc. Nephrol. 2, 715\u2013721. https:\/\/doi.org\/10.2215\/cjn.00470107 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"96782_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1053\/j.ajkd.2010.01.015","volume":"56","author":"JJ Lee","year":"2010","unstructured":"Lee, J. J. et al. Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: A cross-sectional study. Am. J. Kidney Dis. 56, 23\u201331. https:\/\/doi.org\/10.1053\/j.ajkd.2010.01.015 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"96782_CR11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1053\/j.gastro.2016.02.039","volume":"150","author":"Z Younossi","year":"2016","unstructured":"Younossi, Z., Park, H., Henry, L., Adeyemi, A. & Stepanova, M. Extrahepatic manifestations of hepatitis C: A meta-analysis of prevalence, quality of life, and economic burden. Gastroenterology 150, 1599\u20131608. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.039 (2016).","journal-title":"Gastroenterology"},{"key":"96782_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2049936115585942","volume":"3","author":"P Cacoub","year":"2016","unstructured":"Cacoub, P. et al. Extrahepatic manifestations of chronic hepatitis C virus infection. Ther. Adv. Infect Dis. 3, 3\u201314. https:\/\/doi.org\/10.1177\/2049936115585942 (2016).","journal-title":"Ther. Adv. Infect Dis."},{"key":"96782_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fmed.2019.00020","volume":"6","author":"A Angeletti","year":"2019","unstructured":"Angeletti, A., Cantarelli, C. & Cravedi, P. HCV-associated nephropathies in the era of direct acting antiviral agents. Front Med. 6, 20. https:\/\/doi.org\/10.3389\/fmed.2019.00020 (2019).","journal-title":"Front Med."},{"key":"96782_CR14","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1872-034X.2008.00334.x","volume":"38","author":"N Ishizaka","year":"2008","unstructured":"Ishizaka, N. et al. Association between hepatitis B\/C viral infection, chronic kidney disease and insulin resistance in individuals undergoing general health screening. Hepatol. Res. 38, 775\u2013783. https:\/\/doi.org\/10.1111\/j.1872-034X.2008.00334.x (2008).","journal-title":"Hepatol. Res."},{"key":"96782_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/m13-1133","volume":"160","author":"MM Denniston","year":"2014","unstructured":"Denniston, M. M. et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann. Int. Med. 160, 293\u2013300. https:\/\/doi.org\/10.7326\/m13-1133 (2014).","journal-title":"Ann. Int. Med."},{"key":"96782_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s2468-1253(16)30181-9","volume":"2","author":"S Blach","year":"2015","unstructured":"Blach, S. et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study. Lancet Gastroenterol. Hepatol. 2, 161\u2013176. https:\/\/doi.org\/10.1016\/s2468-1253(16)30181-9 (2015).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"96782_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<290::AID-JMV5>3.0.CO;2-R","volume":"59","author":"CA Sun","year":"1999","unstructured":"Sun, C. A. et al. Transmission of hepatitis C virus in Taiwan: Prevalence and risk factors based on a nationwide survey. J. Med. Virol. 59, 290\u2013296 (1999).","journal-title":"J. Med. Virol."},{"key":"96782_CR18","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/jvh.12414","volume":"22","author":"X Tong","year":"2015","unstructured":"Tong, X. & Spradling, P. R. Increase in nonhepatic diagnoses among persons with hepatitis C hospitalized for any cause, United States, 2004\u20132011. J. Viral. Hepat. 22, 906\u2013913. https:\/\/doi.org\/10.1111\/jvh.12414 (2015).","journal-title":"J. Viral. Hepat."},{"key":"96782_CR19","first-page":"434","volume":"8","author":"N Latt","year":"2012","unstructured":"Latt, N., Alachkar, N. & Gurakar, A. Hepatitis C virus and its renal manifestations: A review and update. Gastroenterol. Hepatol. 8, 434\u2013445 (2012).","journal-title":"Gastroenterol. Hepatol."},{"key":"96782_CR20","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1007\/s10620-015-3801-y","volume":"60","author":"F Fabrizi","year":"2015","unstructured":"Fabrizi, F., Verdesca, S., Messa, P. & Martin, P. Hepatitis C virus infection increases the risk of developing chronic kidney disease: A systematic review and meta-analysis. Dig. Dis. Sci. 60, 3801\u20133813. https:\/\/doi.org\/10.1007\/s10620-015-3801-y (2015).","journal-title":"Dig. Dis. Sci."},{"key":"96782_CR21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/hep.29192","volume":"66","author":"TS Lai","year":"2017","unstructured":"Lai, T. S. et al. Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study. Hepatology 66, 784\u2013793. https:\/\/doi.org\/10.1002\/hep.29192 (2017).","journal-title":"Hepatology"},{"key":"96782_CR22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.ajkd.2010.09.023","volume":"57","author":"AA Butt","year":"2011","unstructured":"Butt, A. A., Wang, X. & Fried, L. F. HCV infection and the incidence of CKD. Am. J. Kidney Dis. 57, 396\u2013402. https:\/\/doi.org\/10.1053\/j.ajkd.2010.09.023 (2011).","journal-title":"Am. J. Kidney Dis."},{"key":"96782_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100790","volume":"9","author":"JJ Lee","year":"2014","unstructured":"Lee, J. J. et al. Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis. PLoS ONE 9, e100790. https:\/\/doi.org\/10.1371\/journal.pone.0100790 (2014).","journal-title":"PLoS ONE"},{"key":"96782_CR24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/cts.12321","volume":"8","author":"N Kurbanova","year":"2015","unstructured":"Kurbanova, N. & Qayyum, R. Association of Hepatitis C Virus Infection with Proteinuria and Glomerular Filtration Rate. Clin. Transl. Sci. 8, 421\u2013424. https:\/\/doi.org\/10.1111\/cts.12321 (2015).","journal-title":"Clin. Transl. Sci."},{"key":"96782_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2215\/cjn.06920711","volume":"7","author":"F Fabrizi","year":"2012","unstructured":"Fabrizi, F., Martin, P., Dixit, V. & Messa, P. Hepatitis C virus infection and kidney disease: A meta-analysis. Clin. J. Am. Soc. Nephrol. 7, 549\u2013557. https:\/\/doi.org\/10.2215\/cjn.06920711 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"96782_CR26","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s10620-015-3918-z","volume":"61","author":"SS Rogal","year":"2016","unstructured":"Rogal, S. S. et al. Incidence and progression of chronic kidney disease after hepatitis C seroconversion: Results from ERCHIVES. Dig. Dis. Sci. 61, 930\u2013936. https:\/\/doi.org\/10.1007\/s10620-015-3918-z (2016).","journal-title":"Dig. Dis. Sci."},{"key":"96782_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey, A. S. et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Int. Med. 145, 247\u2013254. https:\/\/doi.org\/10.7326\/0003-4819-145-4-200608150-00004 (2006).","journal-title":"Ann. Int. Med."},{"key":"96782_CR28","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/sim.1047","volume":"21","author":"G Heinze","year":"2002","unstructured":"Heinze, G. & Schemper, M. A solution to the problem of separation in logistic regression. Stat. Med. 21, 2409\u20132419. https:\/\/doi.org\/10.1002\/sim.1047 (2002).","journal-title":"Stat. Med."},{"key":"96782_CR29","doi-asserted-by":"publisher","first-page":"e1334","DOI":"10.1097\/md.0000000000001334","volume":"94","author":"YC Chen","year":"2015","unstructured":"Chen, Y. C., Hwang, S. J., Li, C. Y., Wu, C. P. & Lin, L. C. A taiwanese nationwide cohort study shows interferon-based therapy for chronic hepatitis C reduces the risk of chronic kidney disease. Medicine 94, e1334. https:\/\/doi.org\/10.1097\/md.0000000000001334 (2015).","journal-title":"Medicine"},{"key":"96782_CR30","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2215\/cjn.01530218","volume":"13","author":"SY Tartof","year":"2018","unstructured":"Tartof, S. Y. et al. Kidney function decline in patients with CKD and untreated hepatitis C infection. Clin. J. Am. Soc. Nephrol. 13, 1471\u20131478. https:\/\/doi.org\/10.2215\/cjn.01530218 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"96782_CR31","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.kint.2017.03.021","volume":"92","author":"TS Lai","year":"2017","unstructured":"Lai, T. S. et al. High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease. Kidney Int. 92, 703\u2013709. https:\/\/doi.org\/10.1016\/j.kint.2017.03.021 (2017).","journal-title":"Kidney Int."},{"key":"96782_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2215\/cjn.03710708","volume":"4","author":"N Perico","year":"2009","unstructured":"Perico, N., Cattaneo, D., Bikbov, B. & Remuzzi, G. Hepatitis C infection and chronic renal diseases. Clin. J. Am. Soc. Nephrol. 4, 207\u2013220. https:\/\/doi.org\/10.2215\/cjn.03710708 (2009).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"96782_CR33","doi-asserted-by":"publisher","first-page":"e4203","DOI":"10.1097\/md.0000000000004203","volume":"95","author":"PY Chang","year":"2016","unstructured":"Chang, P. Y. et al. Risk factors of gender for renal progression in patients with early chronic kidney disease. Medicine 95, e4203. https:\/\/doi.org\/10.1097\/md.0000000000004203 (2016).","journal-title":"Medicine"},{"key":"96782_CR34","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s10157-016-1309-1","volume":"21","author":"D Inaguma","year":"2017","unstructured":"Inaguma, D. et al. Risk factors for CKD progression in Japanese patients: Findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study. Clin. Exp. Nephrol. 21, 446\u2013456. https:\/\/doi.org\/10.1007\/s10157-016-1309-1 (2017).","journal-title":"Clin. Exp. Nephrol."},{"key":"96782_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170393","volume":"12","author":"CW Tsai","year":"2017","unstructured":"Tsai, C. W., Lin, S. Y., Kuo, C. C. & Huang, C. C. Serum uric acid and progression of kidney disease: A longitudinal analysis and mini-review. PLoS ONE 12, e0170393. https:\/\/doi.org\/10.1371\/journal.pone.0170393 (2017).","journal-title":"PLoS ONE"},{"key":"96782_CR36","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.4254\/wjh.v9.i36.1352","volume":"9","author":"ES Aby","year":"2017","unstructured":"Aby, E. S., Dong, T. S., Kawamoto, J., Pisegna, J. R. & Benhammou, J. N. Impact of sustained virologic response on chronic kidney disease progression in hepatitis C. World J. Hepatol. 9, 1352\u20131360. https:\/\/doi.org\/10.4254\/wjh.v9.i36.1352 (2017).","journal-title":"World J. Hepatol."},{"key":"96782_CR37","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1136\/gutjnl-2014-308163","volume":"64","author":"YC Hsu","year":"2015","unstructured":"Hsu, Y. C. et al. Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection. Gut 64, 495\u2013503. https:\/\/doi.org\/10.1136\/gutjnl-2014-308163 (2015).","journal-title":"Gut"},{"key":"96782_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.kint.2019.04.030","volume":"97","author":"ME Sise","year":"2020","unstructured":"Sise, M. E. et al. Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease. Kidney Int. 97, 193\u2013201. https:\/\/doi.org\/10.1016\/j.kint.2019.04.030 (2020).","journal-title":"Kidney Int."},{"key":"96782_CR39","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jhep.2019.11.014","volume":"72","author":"CH Liu","year":"2020","unstructured":"Liu, C. H. et al. Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals. J. Hepatol. 72, 839\u2013846. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.014 (2020).","journal-title":"J. Hepatol."},{"key":"96782_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/jvh.13417","volume":"28","author":"S Rafique","year":"2021","unstructured":"Rafique, S. et al. Genome-wide methylation profiling of HCV pathogenesis to develop diabetes and diabetic complications. J. Viral. Hepat. 28, 245\u2013259. https:\/\/doi.org\/10.1111\/jvh.13417 (2021).","journal-title":"J. Viral. Hepat."},{"key":"96782_CR41","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1111\/jcmm.13553","volume":"22","author":"A Singhal","year":"2018","unstructured":"Singhal, A., Agrawal, A. & Ling, J. Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: A driver function of circulating miRNAs. J. Cell Mol. Med. 22, 2071\u20132085. https:\/\/doi.org\/10.1111\/jcmm.13553 (2018).","journal-title":"J. Cell Mol. Med."},{"key":"96782_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017020437","volume":"27","author":"UA Ashfaq","year":"2017","unstructured":"Ashfaq, U. A. & Khalid, H. Mechanism of hepatitis C virus-induced diabetes mellitus. Crit. Rev. Eukaryot Gene Expr. 27, 363\u2013371. https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.2017020437 (2017).","journal-title":"Crit. Rev. Eukaryot Gene Expr."},{"key":"96782_CR43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/liv.13194","volume":"37","author":"YJ Lin","year":"2017","unstructured":"Lin, Y. J. et al. Chronic hepatitis C virus infection and the risk for diabetes: A community-based prospective study. Liver Int. 37, 179\u2013186. https:\/\/doi.org\/10.1111\/liv.13194 (2017).","journal-title":"Liver Int."},{"key":"96782_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11154-017-9440-1","volume":"19","author":"S Fabiani","year":"2018","unstructured":"Fabiani, S., Fallahi, P., Ferrari, S. M., Miccoli, M. & Antonelli, A. Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature. Rev. Endocr. Metab. Disord. 19, 405\u2013420. https:\/\/doi.org\/10.1007\/s11154-017-9440-1 (2018).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"96782_CR45","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2337\/dc17-0485","volume":"40","author":"J Hum","year":"2017","unstructured":"Hum, J. et al. Improvement in glycemic control of type 2 diabetes after successful treatment of hepatitis C virus. Diabetes Care 40, 1173\u20131180. https:\/\/doi.org\/10.2337\/dc17-0485 (2017).","journal-title":"Diabetes Care"},{"key":"96782_CR46","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1111\/dom.14168","volume":"22","author":"LE Adinolfi","year":"2020","unstructured":"Adinolfi, L. E. et al. Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study. Diabetes Obes. Metab. 22, 2408\u20132416. https:\/\/doi.org\/10.1111\/dom.14168 (2020).","journal-title":"Diabetes Obes. Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96782-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96782-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96782-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T13:02:39Z","timestamp":1670072559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96782-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["96782"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-96782-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2021,8,25]]},"assertion":[{"value":"4 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17197"}}